# Merck & Co Inc (NYSE: MRK), North Wales, PA – FDA Inspections

Source: https://www.keypedia.com/companies/merck-co-inc/b31c98fd-1c55-4600-8977-5abbfb1991f5

> Inspection records and compliance data for Merck & Co Inc in North Wales, Pennsylvania. 5 FDA inspections on record, last inspected September 01, 2023. Publicly traded as NYSE: MRK.

---

## Details

- Name: Merck & Co Inc
- FEI Number: 3002721810
- Address Line 1: 351 N Sumneytown Pike
- City: North Wales
- State: Pennsylvania
- Zip Code: 19454
- Country Name: United States
- Address: 351 N Sumneytown Pike, North Wales, Pennsylvania 19454, United States
- Country: United States

## Stock

- Stock ticker: MRK
- Exchange: NYSE
- Share price: $146.99
- Market cap: $362.4B
- Price as of: November 13, 2026

## Related Documents

- [FDA Inspection 1219020 - Merck & Co Inc - 2023-09-01](https://www.keypedia.com/records/fda_inspections/merck-co-inc/b19cee79-d8b2-45a8-848e-1271b06602e6) — classification: No Action Indicated (NAI), source: FDA, date: September 1, 2023
- FDA Inspection 1071196 - Merck & Co Inc - 2018-11-01 — classification: No Action Indicated (NAI), source: FDA, date: November 1, 2018
- [FDA Inspection 988466 - Merck & Co Inc - 2016-09-20](https://www.keypedia.com/records/fda_inspections/merck-co-inc/d94aa913-b79d-4b41-93df-116c588a5faf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 20, 2016
- [FDA Inspection 970042 - Merck & Co Inc - 2016-04-12](https://www.keypedia.com/records/fda_inspections/merck-co-inc/d1f4982a-0958-42be-9e68-10f1ff0457f9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 12, 2016
- [FDA Inspection 849685 - Merck & Co Inc - 2013-10-08](https://www.keypedia.com/records/fda_inspections/merck-co-inc/fbd90269-09c5-47f2-a866-de31e5ac3c10) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 8, 2013
- [EIR - Merck & Co Inc - 2013-06-14](https://www.keypedia.com/records/eir/merck-co-inc/ccb33ac0-ea38-43a2-95d1-abd75756e958) — source: FDA, date: June 14, 2013

## Related Companies

- [Daniel J. DeAngelo, MD](https://www.keypedia.com/companies/daniel-j-deangelo-md/9a6d0cc8-13b8-4412-b0b4-933a9ef1352c)
- [Ranbaxy Inc.](https://www.keypedia.com/companies/ranbaxy-inc/83cb62ce-f991-473a-a24b-f5951066c481)
- [Amryt Pharmaceuticals, Inc.](https://www.keypedia.com/companies/amryt-pharmaceuticals-inc/bfdef8ed-47d6-408f-a59b-16c2f17d796a)
- [Matrixx Initiatives, Inc.](https://www.keypedia.com/companies/matrixx-initiatives-inc/7fbc68ac-c0d4-4034-af19-6bd954d17e4d)
- [Patheon Biologics (NJ) LLC](https://www.keypedia.com/companies/patheon-biologics-nj-llc/5d009aee-a952-4eee-a975-1b2bd0559e04)
- [Silliker Laboratories Group, Inc](https://www.keypedia.com/companies/silliker-laboratories-group-inc/a9d53aca-972c-488b-a699-d41cdadcf067)
- [McGuff Pharmaceuticals, Inc.](https://www.keypedia.com/companies/mcguff-pharmaceuticals-inc/15443041-ed2c-4d7b-8313-9c85fa0f7bc6)
- [Douglas Glenn Young, M.D.](https://www.keypedia.com/companies/douglas-glenn-young-md/8df28cec-c379-4bbf-a055-6f2996fa1da3)
- [U.S. Army Medical Research Institute of Infectious Diseases](https://www.keypedia.com/companies/us-army-medical-research-institute-of-infectious-diseases/6d9547df-bbd2-48e8-ba75-d633d911af27)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/be7fcaee-1b54-4e0d-82a3-85d9c545b073)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/michael-f-skelly/6a862378-5f93-4e47-862c-68a3c7c04d95)
- [investigator](https://www.keypedia.com/people/krystal-ogunremi/f91a439d-8417-4000-9d9c-5582b882d0c8)
